Kim Tommy, Stetson Alyssa, Griggs Cornelia, Masiakos Peter, Chang David, Kelleher Cassandra
Massachusetts General Hospital, Department of Pediatric Surgery, Boston, Massachusetts.
Massachusetts General Hospital, Department of Pediatric Surgery, Boston, Massachusetts.
J Surg Res. 2024 Dec;304:212-217. doi: 10.1016/j.jss.2024.10.017. Epub 2024 Nov 17.
Growing evidence supports the success of nonoperative management (NOM) for pediatric adhesive small bowel obstruction (A-SBO). However, there is concern that patients with nonadhesive SBO (NA-SBO) will have repeat episodes of SBO if not treated with surgery upfront. We examined whether NOM of NA-SBO at initial presentation was associated with increased risk of recurrent SBO.
A single-center observational study was performed using Current Procedural Terminology/International Classification of Disease (ICD) codes and chart review. NA-SBO was defined as SBO in a patient with no history of SBOs, prior abdominal surgeries, or congenital gastrointestinal abnormalities known to cause SBO. We excluded patients with incarcerated hernias and tumors. The independent variable was surgical treatment at initial SBO admission and primary outcome was SBO recurrence within 1 y.
Our cohort included 97 patients, with 30 patients (31%) undergoing surgery at initial NA-SBO admission. There was no difference in rates of recurrent SBO within 1 y when comparing the operative versus nonoperative management groups (6.7% versus 8.9%, P = 0.70). Among patients who recurred, there was no difference in need for surgical intervention (2/6 versus 0/2, P = 0.34). None of the operations for recurrence were urgent or emergent. Patients managed nonoperatively had a shorter median length of stay (2 versus 7 d, P < 0.001) and did not have significantly more emergency room visits (10.4% versus 6.7%, P = 0.55).
NOM of NA-SBO was not associated with increased rates of SBO recurrence, and NOM did not lead to increased morbidity. Surgeons should consider NOM in stable pediatric patients who present with NA-SBO.
越来越多的证据支持小儿粘连性小肠梗阻(A-SBO)非手术治疗(NOM)的成功。然而,有人担心非粘连性SBO(NA-SBO)患者如果不预先进行手术治疗,会反复发生SBO。我们研究了初次就诊时NA-SBO的NOM是否与复发性SBO风险增加相关。
采用当前操作术语/国际疾病分类(ICD)编码和病历回顾进行单中心观察性研究。NA-SBO定义为无SBO病史、既往腹部手术史或已知可导致SBO的先天性胃肠道异常的患者发生的SBO。我们排除了嵌顿疝和肿瘤患者。自变量为初次SBO入院时的手术治疗,主要结局为1年内SBO复发。
我们的队列包括97例患者,其中30例(31%)在初次NA-SBO入院时接受了手术。比较手术治疗组与非手术治疗组,1年内复发性SBO的发生率无差异(6.7%对8.9%,P = 0.70)。在复发的患者中,手术干预的必要性无差异(2/6对0/2,P = 0.34)。复发手术均非紧急或急诊手术。非手术治疗的患者中位住院时间较短(2天对7天,P < 0.001),急诊室就诊次数也无显著增加(10.4%对6.7%,P = 0.55)。
NA-SBO的NOM与SBO复发率增加无关,且NOM不会导致发病率增加。对于出现NA-SBO的稳定小儿患者,外科医生应考虑NOM。